Dalane Kitzman, MD
Cardiovascular Disease · Winston Salem, NCNPI 1396720678
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $186,845 of the $199,001 with a category attached, or 93.9%. 9 manufacturers reported payments, led by GSK at 51.1% of the total. Reporting peaked in 2019 at $91,448 and has fallen 93.7% since, to $5,716 in 2023. Among cardiovascular disease clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 108 payments — averaging $1842.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$102K
- AstraZeneca$34K
- Boehringer Ingelheim International GmbH$22K
- Astrazeneca UK Limited$16K
- Pfizer$9K
- Merck$8K
- plus $9K from 3 others
Across 592 payments — averaging $3299.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$1.4M
- AstraZeneca$255K
- Novo Nordisk AS$214K
- Bayer$53K
- Novartis$18K
- AbbVie$10K
What the payments were for
- Consulting fees$186,84594%
- Speaking & faculty fees$8,2504%
- Travel & lodging$3,3212%
- Food & beverage$5860%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 67 | $101,705 |
| AstraZeneca | 8 | $33,504 |
| Boehringer Ingelheim International GmbH | 10 | $21,588 |
| Astrazeneca UK Limited | 4 | $15,858 |
| Pfizer | 4 | $9,472 |
| Merck | 11 | $8,044 |
| Novartis | 2 | $3,565 |
| Amgen | 1 | $3,016 |
| Novo Nordisk AS | 1 | $2,250 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$199,001 in reported general payments places this provider in the 95th percentile of 727 cardiovascular disease providers in North Carolina.
See all cardiovascular disease providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Winston Salem
- George BodziockWinston Salem$54K
- Patrick KozakWinston Salem$44K
- R WilliamsDurham$2.1M
- Marat FudimDurham$902K
- Jonathan PicciniDurham$767K
- Michael RinaldiCharlotte$722K
- Markus SchererCharlotte$526K
- Robert MentzDurham$489K
- Sean PokorneyMorganton$477K
- Adrian HernandezDurham$409K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.